Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H17NO5S |
Molecular Weight | 335.375 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)COC1=CC=C(CCNS(=O)(=O)C2=CC=CC=C2)C=C1
InChI
InChIKey=XTNWJMVJVSGKLR-UHFFFAOYSA-N
InChI=1S/C16H17NO5S/c18-16(19)12-22-14-8-6-13(7-9-14)10-11-17-23(20,21)15-4-2-1-3-5-15/h1-9,17H,10-12H2,(H,18,19)
Molecular Formula | C16H17NO5S |
Molecular Weight | 335.375 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Sulotroban is a phenoxyalkylcarboxylic acid derivative patented by Boehringer Mannheim G.m.b.H. as thrombocyte aggregation inhibitor and lipid-lowering agent. Sulotroban is the first thromboxane A2 receptor antagonist available for use in man. Its antagonistic profile appeared to be specific and competitive both for platelets and vascular or bronchial smooth muscle receptors. In preclinical models Administered as a single dose of 800 mg, sulotroban antagonized arachidonic acid-induced, collagen-induced, and U-46619-induced platelet aggregation. In clinical trials, Sulotroban shows superior efficacy to placebo in preventing acute problems during, or restenosis after, coronary angioplasty. Chronic dosage with the drug did not lead to any accumulation of its blocking effect on platelet function; the effect of each dose declined to zero 6-7 hours after dosing.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2530714
4 x 800 mg per day
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:31:13 GMT 2023
by
admin
on
Fri Dec 15 15:31:13 GMT 2023
|
Record UNII |
74574CO5A6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1327
Created by
admin on Fri Dec 15 15:31:14 GMT 2023 , Edited by admin on Fri Dec 15 15:31:14 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID80222440
Created by
admin on Fri Dec 15 15:31:14 GMT 2023 , Edited by admin on Fri Dec 15 15:31:14 GMT 2023
|
PRIMARY | |||
|
CHEMBL8273
Created by
admin on Fri Dec 15 15:31:14 GMT 2023 , Edited by admin on Fri Dec 15 15:31:14 GMT 2023
|
PRIMARY | |||
|
C040624
Created by
admin on Fri Dec 15 15:31:14 GMT 2023 , Edited by admin on Fri Dec 15 15:31:14 GMT 2023
|
PRIMARY | |||
|
72131-33-0
Created by
admin on Fri Dec 15 15:31:14 GMT 2023 , Edited by admin on Fri Dec 15 15:31:14 GMT 2023
|
PRIMARY | |||
|
C84190
Created by
admin on Fri Dec 15 15:31:14 GMT 2023 , Edited by admin on Fri Dec 15 15:31:14 GMT 2023
|
PRIMARY | |||
|
5591
Created by
admin on Fri Dec 15 15:31:14 GMT 2023 , Edited by admin on Fri Dec 15 15:31:14 GMT 2023
|
PRIMARY | |||
|
51550
Created by
admin on Fri Dec 15 15:31:14 GMT 2023 , Edited by admin on Fri Dec 15 15:31:14 GMT 2023
|
PRIMARY | |||
|
100000082957
Created by
admin on Fri Dec 15 15:31:14 GMT 2023 , Edited by admin on Fri Dec 15 15:31:14 GMT 2023
|
PRIMARY | |||
|
SUB10756MIG
Created by
admin on Fri Dec 15 15:31:14 GMT 2023 , Edited by admin on Fri Dec 15 15:31:14 GMT 2023
|
PRIMARY | |||
|
74574CO5A6
Created by
admin on Fri Dec 15 15:31:14 GMT 2023 , Edited by admin on Fri Dec 15 15:31:14 GMT 2023
|
PRIMARY | |||
|
AA-84
Created by
admin on Fri Dec 15 15:31:14 GMT 2023 , Edited by admin on Fri Dec 15 15:31:14 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |